| Literature DB >> 25079103 |
Jean-Pierre Droz1, Matti Aapro2, Lodovico Balducci3, Helen Boyle4, Thomas Van den Broeck5, Paul Cathcart6, Louise Dickinson7, Eleni Efstathiou8, Mark Emberton7, John M Fitzpatrick9, Axel Heidenreich10, Simon Hughes11, Steven Joniau5, Michael Kattan12, Nicolas Mottet13, Stéphane Oudard14, Heather Payne15, Fred Saad16, Toru Sugihara12.
Abstract
In 2010, the International Society of Geriatric Oncology (SIOG) developed treatment guidelines for men with prostate cancer who are older than 70 years old. In 2013, a new multidisciplinary SIOG working group was formed to update these recommendations. The consensus of the task force is that older men with prostate cancer should be managed according to their individual health status, not according to age. On the basis of a validated rapid health status screening instrument and simple assessment, the task force recommends that patients are classed into three groups for treatment: healthy or fit patients who should have the same treatment options as younger patients; vulnerable patients with reversible impairment who should receive standard treatment after medical intervention; and frail patients with non-reversible impairment who should receive adapted treatment.Entities:
Mesh：
Substances：
Year: 2014 PMID： 25079103 DOI： 10.1016/S1470-2045(14)70018-X
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316